Company
deCODE genetics
- AI
- Biotech
- Founded:
- 1996
- Location:
- Reykjavik, Iceland
- Parent:
- Amgen
Description
deCODE genetics operates a human gene-discovery engine that analyzes population-scale genomic data to identify genetic risk factors and variants, applying findings to research on diseases such as cardiovascular conditions, cancer, and fibromyalgia.
Related
Orakl OncologyOrakl Oncology builds an AIxBio engine that analyzes multimodal patient data and living biological samples to predict drug responses,…
ORF GeneticsORF Genetics produces animal-free, plant-made recombinant growth factors and cytokines used to support human cell cultures, skincare…
SeqOneSeqOne provides an AI-powered genomic analysis platform that streamlines NGS pipelines, automates file transfer through analysis…
- AplagonAplagon develops a therapeutic called APAC, a vascular-injury targeting molecule that combines antiplatelet, anticoagulant, and…
INNITIUSINNITIUS develops medical hardware and software that measure cervical tissue mechanical properties using torsional-wave sensing and AI to…
HAYA TherapeuticsHAYA Therapeutics develops RNA-guided medicines that use functional genomics and computational tools to identify, target, and monitor…
OphiomicsOphiomics develops diagnostic products combining artificial intelligence and genomics for precision liver medicine, helping clinicians…
ComputomicsComputomics applies machine learning to genomic and bioinformatics data to produce trait discovery, predictive breeding values and…
HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…